1 minute read
We are thrilled to announce that SanaClis, a renowned leader in the pharmaceutical R&D industry, has become an esteemed partner of the...
1 minute read
As of March 2023, SanaClis further strengthens its’ capabilities by receiving a transport license for controlled substances. The license was granted by the Ministry of Health, on the basis of a technical and personnel inspection of the production site performed by the Slovak State Institute for Drug Control.
The license entitles SanaClis to the production, wholesale distribution, import, export, transportation and storage of medicines, and tested products, containing narcotic and psychotropic substances from groups: I, II, III.
Controlled substance clinical trials have generated promising results for many indications, but sponsors need to fully comply with the numerous requirements of using these controlled substances. Managing the accompanying logistical and regulatory requirements remains a big challenge.
Contact our dedicated team and start the conversation today! We will ensure the smooth operations and compliance in your organization’s use of controlled substances for clinical programs.
1 minute read
We are thrilled to announce that SanaClis, a renowned leader in the pharmaceutical R&D industry, has become an esteemed partner of the...
1 minute read
SanaClis has achieved an esteemed AAA credit rating in the Slovak Republic, meeting rigorous economic evaluation criteria established by...
1 minute read
SanaClis is proud to announce that we are supporting Paralympic tennis team player Tomas Masaryk. As a company committed to making a...